A Randomized, Open-label, Single-dose, Parallel-arm, Phase 1 Study to Investigate the Pharmacokinetic Profile of a Fixed-dose Combination Tablet of Tesofensine and Metoprolol (Tesomet) and Co-administration of Tesofensine Plus Commercial Metoprolol in Adult Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 29 May 2018
Price : $35 *
At a glance
- Drugs Metoprolol/tesofensine (Primary) ; Metoprolol; Tesofensine
- Indications Prader-Willi syndrome; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Saniona
- 29 May 2018 According to a Saniona media release, positive results were announced from this trial.
- 04 Apr 2018 Status changed to completed.
- 07 Feb 2018 Acording to a Saniona media release, last participants have had the final visit and the obtained blood samples have been forwarded to a laboratory for analysis.